ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,555.74
-0.16%
US Tech 100
19,095.20
-1.09%
Dow Jones
40,358.09
-0.14%
Brent Oil
80.435
-0.42%
Bitcoin
65,891.22
-0.05%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NovoCure Ltd (NVCR)

  7. NovoCure Ltd (NVCR) News

NVCR

NovoCure (NVCR)

NovoCure Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVCR
DateTimeSourceHeadlineSymbolCompany
07/01/20247:00AMBusiness WireNovocure to Report Second Quarter 2024 Financial ResultsNASDAQ:NVCRNovoCure Ltd
06/10/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCRNovoCure Ltd
06/06/20246:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
06/06/20246:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
06/06/20245:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
06/03/20248:00AMBusiness WireMETIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free SurvivalNASDAQ:NVCRNovoCure Ltd
05/24/20249:06AMBusiness WireTIGER-Studie berichtet über neue Überlebensergebnisse der TTFields-Therapie bei neu diagnostizierten Glioblastom-Patienten in DeutschlandNASDAQ:NVCRNovoCure Ltd
05/23/20245:05PMBusiness WireTIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in GermanyNASDAQ:NVCRNovoCure Ltd
05/20/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCRNovoCure Ltd
05/02/20247:01AMBusiness WireNovocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from PharmakonNASDAQ:NVCRNovoCure Ltd
05/02/20247:00AMBusiness WireNovocure Reports First Quarter 2024 Financial ResultsNASDAQ:NVCRNovoCure Ltd
04/24/202410:45AMBusiness WireResults of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024NASDAQ:NVCRNovoCure Ltd
04/05/20247:00AMBusiness WireNovocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:NVCRNovoCure Ltd
04/01/20247:00AMBusiness WireNovocure to Report First Quarter 2024 Financial ResultsNASDAQ:NVCRNovoCure Ltd
03/28/20248:07PMBusiness WireMETIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長NASDAQ:NVCRNovoCure Ltd
03/28/20241:51PMBusiness WireKlinische Phase-3-Studie METIS erreicht primären Endpunkt und zeigt eine statistisch signifikante Verlängerung der Zeit bis zur intrakraniellen Progression bei Patient:innen mit Hirnmetastasen von nicht-kleinzelligem LungenkrebsNASDAQ:NVCRNovoCure Ltd
03/28/20241:50PMBusiness WireL’essai clinique de phase 3 METIS a atteint son critère principal, démontrant un allongement statistiquement significatif du délai médian jusqu’à la progression intracrânienne chez les patients porteurs de métastases cérébrales consécutives..NASDAQ:NVCRNovoCure Ltd
03/27/20247:00AMBusiness WireMETIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung CancerNASDAQ:NVCRNovoCure Ltd
03/11/20247:00AMBusiness WireINNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGONASDAQ:NVCRNovoCure Ltd
03/05/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
03/04/20246:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVCRNovoCure Ltd
03/04/20245:56PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVCRNovoCure Ltd
03/01/20245:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVCRNovoCure Ltd
03/01/20245:01PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVCRNovoCure Ltd
02/29/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
02/29/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
02/29/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
02/29/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
02/29/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCRNovoCure Ltd
02/22/20247:11AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVCRNovoCure Ltd
 Showing the most relevant articles for your search:NASDAQ:NVCR

Your Recent History

USOTC
NWPN
Now (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
RONN
Ronn Motor (PK)
USOTC
ITUP
Interups (CE)
USOTC
ENZC
Enzolytics (PK)
USOTC
AABB
Asia Broadband (PK)
NASDAQ
TSLA
Tesla
NYSE
AMC
AMC Entertainment
NASDAQ
NB
NioCorp Developments
USOTC
IDVV
International Endeavors (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
COOP
Mr Cooper
USOTC
SMCE
SMC Entertainment (PK)
USOTC
LQMT
Liquidmetal Technologies (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved